AU1904388A – Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
– Google Patents
AU1904388A – Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
– Google Patents
Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
Info
Publication number
AU1904388A
AU1904388A
AU19043/88A
AU1904388A
AU1904388A
AU 1904388 A
AU1904388 A
AU 1904388A
AU 19043/88 A
AU19043/88 A
AU 19043/88A
AU 1904388 A
AU1904388 A
AU 1904388A
AU 1904388 A
AU1904388 A
AU 1904388A
Authority
AU
Australia
Prior art keywords
lens capsule
posterior lens
mitotic inhibitor
capsule opacification
extracapsular extraction
Prior art date
1987-07-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU19043/88A
Other versions
AU602993B2
(en
Inventor
Ihab Hamel
Thomsen J. Hansen
David B. Soll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ophthalmic Research Corp
Drexel University
Original Assignee
Ophthalmic Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-07-16
Filing date
1988-07-14
Publication date
1989-01-19
1988-07-14
Application filed by Ophthalmic Research Corp
filed
Critical
Ophthalmic Research Corp
1989-01-19
Publication of AU1904388A
publication
Critical
patent/AU1904388A/en
1990-11-01
Application granted
granted
Critical
1990-11-01
Publication of AU602993B2
publication
Critical
patent/AU602993B2/en
2008-07-14
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
A61F2/02—Prostheses implantable into the body
A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
A61F2/16—Intraocular lenses
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
A61F2/02—Prostheses implantable into the body
A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
A61F2/16—Intraocular lenses
A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
A61L27/54—Biologically active materials, e.g. therapeutic substances
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A61P27/12—Ophthalmic agents for cataracts
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
A61F2/02—Prostheses implantable into the body
A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
A61F2/16—Intraocular lenses
A61F2/1602—Corrective lenses for use in addition to the natural lenses of the eyes or for pseudo-phakic eyes
A61F2/1605—Anterior chamber lenses for use in addition to the natural lenses of the eyes, e.g. iris fixated, iris floating
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
A61F2/02—Prostheses implantable into the body
A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
A61F2/16—Intraocular lenses
A61F2/1602—Corrective lenses for use in addition to the natural lenses of the eyes or for pseudo-phakic eyes
A61F2/161—Posterior chamber lenses for use in addition to the natural lenses of the eyes
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
A61F2002/009—Special surfaces of prostheses, e.g. for improving ingrowth for hindering or preventing attachment of biological tissue
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
A61L2300/432—Inhibitors, antagonists
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
AU19043/88A
1987-07-16
1988-07-14
Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
Ceased
AU602993B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US074444
1987-07-16
US07/074,444
US4918165A
(en)
1987-07-16
1987-07-16
Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
Publications (2)
Publication Number
Publication Date
AU1904388A
true
AU1904388A
(en)
1989-01-19
AU602993B2
AU602993B2
(en)
1990-11-01
Family
ID=22119581
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU19043/88A
Ceased
AU602993B2
(en)
1987-07-16
1988-07-14
Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
Country Status (5)
Country
Link
US
(1)
US4918165A
(en)
EP
(1)
EP0299467A1
(en)
JP
(1)
JP2767428B2
(en)
AU
(1)
AU602993B2
(en)
CA
(1)
CA1339770C
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU619328B2
(en)
*
1988-08-08
1992-01-23
Eli Lilly And Company
Cytotoxic drug conjugates
Families Citing this family (31)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5080647A
(en)
*
1988-03-25
1992-01-14
Seymour Dubroff
Composition for preventing clouding of posterior capsule after extracapsular cataract eye surgery and method of performing cataract surgery
WO1995003783A1
(en)
*
1990-03-06
1995-02-09
Houston Biotechnology Incorporated
Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
EP0446399A1
(en)
*
1990-03-16
1991-09-18
Chiron Adatomed Pharmazeutische und Medizintechnische Gesellschaft mbH
Solution inhibiting cell growth
EP0567627A4
(en)
*
1991-11-14
1994-06-22
Stanley Poler
Secondary eye growth impeding device and method
US5354269A
(en)
*
1991-12-20
1994-10-11
Fibrogenex, Inc.
Method for treating cancer resections
US5375611A
(en)
*
1993-01-26
1994-12-27
Pharmacia Ab
Method for preventing secondary cataract
US5382582A
(en)
*
1993-03-26
1995-01-17
Chan; Carcy L.
Methotrexate analogs and methods of using same
US5876438A
(en)
*
1993-08-02
1999-03-02
Houston Biotechnology Incorporated
Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
US5834215A
(en)
*
1994-10-05
1998-11-10
The Administrators Of The Tulane Educational Fund
Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)
US5620013A
(en)
*
1994-10-21
1997-04-15
American Cyanamid Company
Method for destroying residual lens epithelial cells
US6063116A
(en)
*
1994-10-26
2000-05-16
Medarex, Inc.
Modulation of cell proliferation and wound healing
US5698556A
(en)
*
1995-06-07
1997-12-16
Chan; Carcy L.
Methotrexate analogs and methods of using same
US5554187A
(en)
*
1995-08-18
1996-09-10
Rizzo, Iii; Joseph
Medication dispensing intra-ocular lens system
US5843186A
(en)
*
1996-12-20
1998-12-01
Implemed, Inc.
Intraocular lens with antimicrobial activity
BR9908779A
(en)
1998-04-15
2000-12-05
Alcon Lab Inc
Compositions for intraocular lens coating
US6491721B2
(en)
1998-04-15
2002-12-10
Alcon Manufacturing, Ltd.
Toric intraocular lens material
US6482230B1
(en)
1998-04-15
2002-11-19
Alcon Manufacturing, Ltd.
Lens epithelial cell growth assay for intraocular lens materials
US6455318B1
(en)
1998-04-15
2002-09-24
Alcon Manufacturing, Ltd.
Collagen IV adhesion assay for intraocular lens materials
WO1999052571A1
(en)
1998-04-15
1999-10-21
Alcon Laboratories, Inc.
Bicomposite intraocular lens and method for its preparation
US6106554A
(en)
*
1999-02-25
2000-08-22
Bausch & Lomb Surgical, Inc.
Intraocular lens implants for the prevention of secondary cataracts
US6454802B1
(en)
2000-08-21
2002-09-24
Bausch & Lomb Incorporated
Intraocular lens implant for the prevention of secondary cataracts
DE60131773T2
(en)
2000-09-06
2008-04-10
Alcon Inc.
COATING AGENT WITH CHANGED ADHESIVITY FOR EYE IMPLANTS
JP2004518649A
(en)
*
2000-12-11
2004-06-24
ムーアフィールズ アイ ホスピタル エヌエイチエス トラスト
Treatment of late cataract
US6703466B1
(en)
2001-06-18
2004-03-09
Alcon, Inc.
Foldable intraocular lens optics having a glassy surface
DE60219189T2
(en)
*
2001-07-20
2008-01-03
Iomed, Inc., Salt Lake City
IOPOPHORETIC OKULAR DEVICE FOR DISTRIBUTING METHOTATEX-BASED MEDICAMENTS AND USE THEREOF FOR THE TREATMENT OF NEOPLASTIC, ANGIOGENIC, FIBROPLASTIC AND / OR IMMUNOSUPPRESSIVE EYE-BREAKING MEASURES
AU2004222653C1
(en)
2003-03-17
2010-10-07
Amo Groningen B.V.
New method
WO2006031614A2
(en)
*
2004-09-10
2006-03-23
Tosk, Inc.
Reduced toxicity methotrexate formulations and methods for using the same
KR20080082659A
(en)
2005-11-28
2008-09-11
버논 디. 로웨
Compositions useful for reducing nephrotoxicity and methods of use thereof
CN102014919B
(en)
2008-03-03
2015-02-25
托斯克公司
Methotrexate adjuvants to reduce toxicity and methods for using the same
US20110082543A1
(en)
*
2009-10-06
2011-04-07
Cleo Cosmetic And Pharmaceutical Company, Llc
Methods and Devices for Preventing or Delaying Posterior Capsule Opacification
US20120191185A1
(en)
*
2011-01-26
2012-07-26
Micheal Colvin
Ophthalmic intraocular lens for promoting healing
Family Cites Families (6)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB2020180B
(en)
*
1978-05-08
1982-08-25
Nelson Res & Dev
Ophthalmic compositions containingcolchicine or vinblastinr
US4515794A
(en)
*
1981-10-09
1985-05-07
Baylor College Of Medicine
Mitotic inhibitors preventing posterior lens capsule opacification
DE3271414D1
(en)
*
1981-10-09
1986-07-03
Baylor College Medicine
Use of methotrexate and/or retinoic acid for the manufacture of compositions for use in preventing proliferation of remnant lens epithelial cells after extracapsular extraction
US4399460A
(en)
*
1981-10-09
1983-08-16
Rca Corporation
Video signal peaking control system with provision for automatic and manual control
US4432751A
(en)
*
1982-03-05
1984-02-21
Baylor College Of Medicine
Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction
US4699784A
(en)
*
1986-02-25
1987-10-13
Center For Molecular Medicine & Immunology
Tumoricidal methotrexate-antibody conjugate
1987
1987-07-16
US
US07/074,444
patent/US4918165A/en
not_active
Expired – Lifetime
1988
1988-07-14
EP
EP88111290A
patent/EP0299467A1/en
not_active
Withdrawn
1988-07-14
AU
AU19043/88A
patent/AU602993B2/en
not_active
Ceased
1988-07-15
JP
JP63175259A
patent/JP2767428B2/en
not_active
Expired – Fee Related
1988-07-15
CA
CA000572099A
patent/CA1339770C/en
not_active
Expired – Fee Related
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU619328B2
(en)
*
1988-08-08
1992-01-23
Eli Lilly And Company
Cytotoxic drug conjugates
Also Published As
Publication number
Publication date
US4918165A
(en)
1990-04-17
JP2767428B2
(en)
1998-06-18
AU602993B2
(en)
1990-11-01
EP0299467A1
(en)
1989-01-18
CA1339770C
(en)
1998-03-24
JPH01100133A
(en)
1989-04-18
Similar Documents
Publication
Publication Date
Title
AU1904388A
(en)
1989-01-19
Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
EP0356372A3
(en)
1990-03-14
Cataract removal technique
AU7911987A
(en)
1988-03-08
Method and apparatus for packaging an intraocular lens
AU610207B2
(en)
1991-05-16
Method for priming hard tissue
AU1687588A
(en)
1988-12-02
Intraocular lens implantation
AU3054689A
(en)
1990-08-24
Intraocular lens
ZA89855B
(en)
1989-10-25
Method for preventing secondary effects
AU566203B2
(en)
1987-10-15
Deformable intraoccular lens and method of implantation
AU3461089A
(en)
1989-11-16
Anterior chamber intraocular implant
AU7308591A
(en)
1991-09-03
Apparatus for implantation and extraction of prostheses
AU4606789A
(en)
1991-07-18
Lenses from polymeric derivatives of carylic and methacrylic acids
GR880100491A
(en)
1989-04-12
Method for the preparation of aketaminophane formulations orally slowly released
AU1204588A
(en)
1988-08-25
Gelatin coated caplets and process for making same
EP0226425A3
(en)
1989-07-05
Multi-part intraocular lens and method of implanting it in an eye
EP0099641A3
(en)
1984-11-14
Intraocular lens and method of inserting an intraocular lens into an eye
GB2120937B
(en)
1986-07-09
Implant for sustained release of pharmaceutical agents
AU2883289A
(en)
1989-07-27
Intraocular lens
EP0294277A3
(en)
1989-06-28
A method for the preparation of an organopolysiloxane
GB2226246B
(en)
1992-04-15
Intraocular lens
CS258888A1
(en)
1990-08-14
Stable soft gelatine capsules
GB2191695B
(en)
1990-11-28
An ophthalmic pharmaceutical composition for cataract
EP0348732A3
(en)
1990-07-04
Rotational-speed synchronisation method
AU3021589A
(en)
1989-09-21
Intraocular lens
AU1316188A
(en)
1988-09-15
Method of inhibiting interleukin-1 release
AU2468288A
(en)
1989-05-04
Photohardenable electrostatic master having improved backtransfer and charge decay
None